SCA
SILK

Spearhead Capital Advisors’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Spearhead Capital Advisors’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,427
Closed -$270K – 180
2022
Q2 		$270K Sell
7,427
-109
-1% -$3.96K 0.04% 134
2022
Q1 		$311K Buy
+7,536
New +$265K 0.04% 131

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Spearhead Capital Advisors's SILK Position: Q3 2022 in Review

Spearhead Capital Advisors sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2022, closing a stake of 7,427 shares — an estimated $270K sold.

Spearhead Capital Advisors first reported a position in SILK in Q1 2022 and held it in 2 quarters. The position peaked at $311K in Q1 2022. 147 funds tracked by Wall St. Rank hold SILK as of Q3 2022.

  • Spearhead Capital Advisors reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Spearhead Capital Advisors sold 7,427 Silk Road Medical, Inc. Common Stock shares in Q3 2022, an estimated $270K.
  • Spearhead Capital Advisors first reported a position in Silk Road Medical, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Spearhead Capital Advisors's Silk Road Medical, Inc. Common Stock position peaked at $311K in Q1 2022.
  • 147 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2022.

Based on Spearhead Capital Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.